AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Postmenopausal estrogen linked to improved cognition: retrospective analysis.(News)
MIAMI BEACH -- Postmenopausal estrogen users performed significantly better on computerized cognitive tests than nonusers, suggesting that the hormone may have a beneficial effect on cognition in some women, Joan Friebely, Ed.D., reported in a poster session at the annual meeting of the North American Menopause Society.
Dr. Friebely's conclusions, which indicated intact working memory and executive function, support the hypothesis that estrogen may have a protective effect on cognition when administered to younger, healthy postmenopausal women like those included in her analysis. Other computerized tests of cognition have not examined similar populations.
"We looked at healthy women who were within a relatively short time after their final menstrual period and who started using estrogen early, in that critical period before any [cognitive] damage was done," ...
- Postmenopausal estrogen guidelines for treating hot flashes released.
- Magazine article from: Women's Health Weekly May 27, 2004 700+ words
...Medical Association. "Use of postmenopausal estrogen has changed since the release...current state of evidence for postmenopausal estrogen use to management decisions in...American Medical Association (Postmenopausal estrogen for treatment of hot flashes...
- Postmenopausal estrogen does not improve cognitive function.(POEMs:...
- Magazine article from: JAAPA-Journal of the American Academy of Physicians Assistants September 1, 2004 700+ words
Clinical question Does postmenopausal estrogen therapy improve global cognitive function? Bottom line Postmenopausal estrogen therapy does not improve--and may worsen--global cognitive function. Adverse effects may be more pronounced in...
- Boning up on postmenopausal hormones. (Postmenopausal Estrogen-Progestin...
- Magazine article from: Science News Raloff, Janet November 9, 1996 700+ words
...heighten the risk of heart disease. The federally funded Postmenopausal Estrogen-Progestin Interventions (PEPI) trial was designed...Warner-Lambert tested various doses of an experimental postmenopausal estrogen-progestin mix. They found that low doses of the same...
- Postmenopausal estrogen replacement therapy: Understanding the benefits and the...
- Magazine article from: Townsend Letter for Doctors and Patients Hudson, Tori February 1, 2002 700+ words
By the year 2015, nearly 50% of the women in the United States will be menopausal. Between 1990 and 2020, the menopausal population in the US will double. This dramatic increase in the number of menopausal women, is changing the way health care providers work with women, and changing medicine
- Postmenopausal Estrogen-Progestin Therapy and Breast Cancer.
- Magazine article from: Internal Medicine Alert April 29, 2000 700+ words
ABSTRACT & COMMENTARY Synopsis: Ross and colleagues conclude that the addition of a progestin to an estrogen postmenopausal regimen increases the risk of breast cancer compared with the use of estrogen alone. Source: Ross RK, et al. J Natl Cancer Inst 2000;92:328-332. ROSS AND COLLEAGUES FROM
- FDA panel considers postmenopausal estrogen plus progestin.
- Newspaper article from: Medical Letter on the CDC & FDA November 9, 2003 700+ words
2003 NOV 9 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) met recently to discuss the use of Wyeth's estrogen plus progestin (E+P) hormone therapy product, Prempro (conjugated estrogens/medroxyprogesterone
- Cerebral Metabolism in Postmenopausal Estrogen Therapy
- Magazine article from: The Journal of Nuclear Medicine Anonymous August 1, 2008 700+ words
In an article e-published on June 6 ahead of print in Neurochemical Research, Kenna et al. from the Stanford University School of Medicine (CA) reported on an ^sup 18^F-FDG PET study comparing regional cerebral brain metabolism in 11 healthy postmenopausal women on estrogen therapy and a similar
- FDA Advisory Committee Considers Postmenopausal Estrogen + Progestin Therapy...
- Press release article from: PR Newswire October 8, 2003 700+ words
MADISON, N.J., Oct. 8 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) met yesterday to discuss the use of Wyeth's estrogen plus progestin (E+P) hormone therapy product, PREMPRO(TM) (conjugated estrogens/medroxyprogesterone
